English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/74600
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Compounds for treating neurodegenerative disorders

Other TitlesCompuestos para el tratamiento de enfermedades neurodegenerativas
Composés pour le traitement de maladies neurodégénératives
AuthorsMellström, Britt; Villar, Diego; Dierssen, M.; Naranjo, José Ramón
Issue Date19-Jul-2012
CitationWO2012095548 A2
Abstract[EN] The invention relates to a method for treating neurodegenerative disorders and, in particular, Huntington's disease, by means of the use of DREAM protein inhibitors and, in particular, of different molecules from the glinide family, such as Repaglinide.
[ES] La invención se relaciona con un método para el tratamiento de enfermedades neurodegenerativas y, en particular, de la enfermedad de Huntington, mediante el uso de inhibidores de la proteína DREAM y, en particular, de distintas moléculas de la familia de las glinidas como la Repaglinida.
[FR] L'invention concerne une méthode de traitement de maladies neurodégénératives et, en particulier, de la maladie de Huntington, au moyen de l'utilisation d'inhibiteurs de la protéine DREAM et, en particulier, de molécules distinctes de la famille des glinides, telles que la Répaglinide.
URIhttp://hdl.handle.net/10261/74600
Appears in Collections:(CNB) Patentes
Files in This Item:
File Description SizeFormat 
WO2012095548A2.pdf1,95 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.